Vimarsana
Biggest News Aggregation in the World

Hiroki Kitai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hiroki Kitai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hiroki Kitai Today - Breaking & Trending Today

MicroRNA affects inflammation in lupus disease: Research - Vimarsana News

MicroRNA affects inflammation in lupus disease: Research

Researchers from Nagoya University's Graduate School of Medicine in Japan have uncovered how microRNA (miRNA) affects inflammation in mice with lupus

Health News | MicroRNA Affects Inflammation in Lupus Disease: Research - Vimarsana News

Health News | MicroRNA Affects Inflammation in Lupus Disease: Research

Get latest articles and stories on Health at LatestLY. A group of researchers from the Graduate School of Medicine at Nagoya University in Japan have discovered the impact of microRNA (miRNA) on inflammation in lupus in mice. They identified two miRNAs that are downregulated in the disease and an uncommon situation that occurs in which multiple miRNAs regulate the same set of genes. Health News | MicroRNA Affects Inflammation in Lupus Disease: Research.

Scientists find that microRNA affects inflammation in lupus disease - Vimarsana News

Scientists find that microRNA affects inflammation in lupus disease

A group of researchers from the Graduate School of Medicine at Nagoya University in Japan have discovered the impact of microRNA (miRNA) on inflammation in lupu

Researchers discover the impact of microRNA on inflammation in lupus - Vimarsana News

Researchers discover the impact of microRNA on inflammation in lupus

A group of researchers from the Graduate School of Medicine at Nagoya University in Japan have discovered the impact of microRNA (miRNA) on inflammation in lupus in mice.

Lupus treatment hope from Japanese miRNA research - Vimarsana News

Lupus treatment hope from Japanese miRNA research

Testing for downregulation of miRNAs may help identify lupus patients who may benefit from specific treatment, according to the research.